Evidence map›Paper›PMID 33207739›Full record

ArticleBiomedicines2020

8-Hydroxydaidzein, an Isoflavone from Fermented Soybean, Induces Autophagy, Apoptosis, Differentiation, and Degradation of Oncoprotein BCR-ABL in K562 Cells.

Pei-Shan Wu, Jui-Hung Yen, Chih-Yang Wang, Pei-Yi Chen, Jui-Hsiang Hung, Ming-Jiuan Wu

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Involvement of Canonical NFκB Pathway in Megakaryocyte Differentiation Induction by Nanocurcumin.International journal of hematology-oncology and stem cell research · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Pei-Shan WuDepartment of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan 717, Taiwan.
Jui-Hung YenDepartment of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970, Taiwan.
Chih-Yang WangPh.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University, Taipei 11031, Taiwan.
Pei-Yi ChenDepartment of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970, Taiwan.
Jui-Hsiang HungDepartment of Biotechnology, Chia Nan University of Pharmacy and Science, Tainan 717, Taiwan.
Ming-Jiuan WuDepartment of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan 717, Taiwan.ORCID 0000-0003-3327-828X
Chia Nan University of Pharmacy and Science · TWTzu Chi University · TWTaipei Medical University · TW

Funding

Ministry of Science and Technology, Taiwan MOST-106-2320-B-041-006-MY3; MOST-108-2320-B-320-002-MY3
6 · The paper itself

Abstract

8-Hydroxydaidzein (8-OHD, 7,8,4'-trihydoxyisoflavone) is a hydroxylated derivative of daidzein isolated from fermented soybean products. The aim of this study is to investigate the anti-proliferative effects and the underlying mechanisms of 8-OHD in K562 human chronic myeloid leukemia (CML) cells. We found that 8-OHD induced reactive oxygen species (ROS) overproduction and cell cycle arrest at the S phase by upregulating p21

Indexed as

8-hydroxydaidzeinapoptosisautophagyBCR-ABLK562MAPKNF-κB

Identifiers

PMID33207739
PMCPMC7696406
OpenAlexW3098176099

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.